Abstract
Prostate cancer detection and management continues to be an area of immense study, debate, and controversy. Despite the best efforts of urologists, radiation oncologists, and medical oncologists, some men will die of prostate cancer despite the currently available options for prostate cancer treatment. On the opposite end of the spectrum from that aggressive form of prostate cancer is the indolent prostate cancer that never affects the man who bears the diagnosis. Thus, this creates a primary problem in the use of prostate cancer screening: some men with aggressive prostate cancer may not be readily identified and treated despite efforts at prostate cancer screening and biopsy; however, other men who have an indolent small volume prostate cancer are unlikely to be harmed from the prostate cancer itself but are subjected to the side effects associated with treatment.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
